Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

949
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
949
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Clinical Trials01:16

Clinical Trials

9.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.5K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

744
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
744
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

879
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
879

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Post-approval outcomes of voretigene neparvovec (Luxturna®) retinal gene therapy: A systematic review and meta-analysis.

Survey of ophthalmology·2026
Same author

UCHL1-Related Dominant Optic Atrophy: Report of Two New Families.

Neuro-ophthalmology (Aeolus Press)·2026
Same author

Radial outer retina reflectivity (RORR) sign in LAMP2-associated retinopathy.

Acta ophthalmologica·2026
Same author

Visual acuities in patients with autosomal recessive retinitis pigmentosa associated with four rod phototransduction genes.

Eye (London, England)·2026
Same author

The quality-of-life impacts and economic burden of X-linked retinitis pigmentosa caused by variants in RPGR.

Eye (London, England)·2026
Same author

Whole-genome sequencing uncovers diverse genetic causes and phenotypic signatures in infantile nystagmus and albinism.

NPJ genomic medicine·2026

Related Experiment Video

Updated: Oct 5, 2025

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

13.2K

Vision at the limits: Absolute threshold, visual function, and outcomes in clinical trials.

Matthew P Simunovic1, John R Grigg1, Omar A Mahroo2

  • 1Save Sight Institute, University of Sydney, Sydney, Australia; Sydney Eye Hospital Sydney, Australia.

Survey of Ophthalmology
|January 30, 2022
PubMed
Summary

Research explores individual differences in vision at absolute threshold, crucial for assessing new retinal disease treatments. New technologies and clinical tests are advancing the evaluation of visual function at its limits.

Keywords:
ElectrophysiologyFull-field stimulus testing (FST)Full-field stimulus thresholdMulti-luminance mobility testing (MLMT)Photopic visionPsychophysicsRetinaScotopic vision

More Related Videos

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

586
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

753

Related Experiment Videos

Last Updated: Oct 5, 2025

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

13.2K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

586
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

753

Area of Science:

  • Ophthalmology
  • Visual Neuroscience
  • Psychophysics

Background:

  • Individual differences in perception at absolute threshold have historical significance.
  • Interest is resurging due to novel retinal disease therapies requiring sensitive outcome measures.
  • Current clinical methods may disproportionately detect rod, not cone, abnormalities in outer retinal diseases.

Purpose of the Study:

  • To review the physical and physiological basis of absolute threshold and dark adaptation.
  • To discuss experimental psychophysical and electrophysiological methods for studying vision at absolute threshold.
  • To provide an overview of current clinical tests for vision at absolute threshold.

Main Methods:

  • Review of historical and current literature on visual perception at absolute threshold.
  • Discussion of psychophysical and electrophysiological experimental approaches.
  • Overview of commercialized devices and clinical tests for absolute threshold and dark adaptation.

Main Results:

  • Recent advancements include devices for assessing absolute threshold and dark adaptation, even with fixation instability.
  • New tests integrate cognitive and motor demands, mimicking daily living activities.
  • There's a need for improved methods to assess cone sensitivity at absolute threshold.

Conclusions:

  • Understanding vision at absolute threshold is vital for evaluating emerging retinal therapies.
  • Technological advancements are improving the assessment of visual function at the limits of vision.
  • Asymmetrical testing methods may need re-evaluation to accurately assess outer retinal diseases.